Major Changes in Store for HIV Market

August 2010
Pharmaceutical Representative;Aug2010, Vol. 40 Issue 8, p8
The article reports on the claims of DataMonitor that the expirations of major patent will affect the pharmaceutical sales of HIV markets in 2019 in the U.S.


Related Articles

  • New Center for Pharma Training. Branch Jr., Al // Pharmaceutical Executive;Dec2002, Vol. 22 Issue 12, p82 

    Focuses on the sales management for pharmaceutical training in the U.S. Launch of the Center for Pharmaceutical Training; Manufacturing principles of pharmaceutical companies; Improvement of the ability to market pharmaceutical product.

  • Wireless hand-helds focus on field force efficiency.  // Medical Marketing & Media;May2002, Vol. 37 Issue 5, p30 

    Reports on the development of wireless sales force automation (SFA) for the pharmaceutical industry. Introduction of the Mobile Pharma by AvantGo Inc.; Importance of the product on sales representatives; Usability of SFA on improving the quality of patient-physician interaction.

  • Seismic changes transform the chain drug industry.  // Chain Drug Review;4/22/2013, Vol. 35 Issue 7, p51 

    The article offers information on the sales figures for the chain drug industry of the U.S. in 2012 with a total sale of 261 billion U.S. dollars and also discusses the effect of seismic changes on the chain drug industry.

  • Death of a salesman? Martindale, Diane // New Scientist;2/28/2004, Vol. 181 Issue 2436, p50 

    Today's pharmaceutical representatives face challenges never imaged by their predecessors. Representatives used to spend years building close relationships with doctors. Now they are lucky to get 90 seconds for a pitch and computer software tracks their sales. Fewer new drugs are appearing on...

  • Patents--whose rights do they serve? Schwartz, Harry // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p26 

    Examines the central role of patents to the pharmaceutical industry. Importance of patent protection for the progress of research; Arguments against patents; Loosening of patents in the United States; CellPro's development of a cell-sorting device to select and segregate certain key portions of...

  • BIG LOSSES DUE AS DRUGS COME OFF PATENT.  // H&HN: Hospitals & Health Networks;09/05/97, Vol. 71 Issue 17, p95 

    Reports on 40 drugmakers who are trying to maintain market share as some profitable patents expire by the year 2003. Strategy of other pharmaceutical company to maintain patency; Amount to lose on the expiration of patents on Pepcid and three other medication.

  • Drug industry urges administration to come down on Argentinian piracy.  // Chemical Market Reporter;01/13/97, Vol. 251 Issue 2, p16 

    Reports on the pharmaceutical industry's call on US President Bill Clinton's administration to retaliate against Argentina for allowing widespread piracy of American drug patents. Estimated losses incurred by the domestic drug industry due to ineffective patent protection by the Argentinian...

  • One More Flat Year, But Just Wait For 2003-2005! Rubin, Jami // Medical Marketing & Media;Jan2002, Vol. 37 Issue 1, p38 

    Focuses on the effects of patent expirations on the performance of several pharmaceutical firms. Assessment on the revenue growth of various companies; Decrease of earnings; Comparison of sales between the year 2001 and 2002.

  • Local Drug Makers Part of Chase for $100B in Patents. Reed, Vita // Orange County Business Journal;9/19/2011, Vol. 34 Issue 38, p4 

    The article reports that Orange County, California-based generic and branded drug companies, including Alergan Inc., Par Pharmaceuticals Inc. and Anchen Inc., are in conflict over 100 million-dollar worth of drugs due to come off patent over the next two years.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics